Pure Global
NCT06286241

Comparison of the Complications in Multiple Myeloma Patients Who Received Autologous Stem Cell Transplantation Between in HEPA-filtered Room and Non-HEPA-filtered Room

Siriraj Hospital·ClinicalTrials.govNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Multiple Myeloma
Study type
Observational
Sponsor & location
Primary sponsor
Siriraj Hospital
Timeline & enrollment
Phase
N/A
Start date
Mar 25, 2024
End date
Jul 30, 2024
Enrollment
344 participants
Primary outcome

febrile neutropenia,Infection,duration of admission,progression free survival

Summary

The goal of this observational study is to comparison of the complications in multiple
 myeloma patients who received autologous stem cell transplantation between in HEPA-filtered
 room and non-HEPA-filtered room. The main questions it aims to answer are:
 
 - The incidence of febrile neutropenia, infection, and duration of hospital stay
 
 - 2-year progression free survival Participants will be collected the data of baseline
 diagnosis, treatment, treatment results and complications during admission and follow-up
 visits from hospital medical record.

ICD-10 classifications
Multiple myelomaMultiple myeloma and malignant plasma cell neoplasmsOther myeloid leukaemiaMyeloid leukaemiaOther myelodysplastic syndromes
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06286241
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06286241 through Pure Global AI's free database. This phase not specified trial is sponsored by Siriraj Hospital and is currently Not yet recruiting. The study focuses on Multiple Myeloma. Target enrollment is 344 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.